How Should We Consider Lupus Without Antinuclear Antibodies? (Record no. 28659095)

MARC details
000 -LEADER
fixed length control field 00818 a2200241 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250517230653.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202002s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 2151-4658
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1002/acr.23714
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Daikh, David I
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200217
245 00 - TITLE STATEMENT
Title How Should We Consider Lupus Without Antinuclear Antibodies?
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Arthritis care & research
Date of publication, distribution, etc. 07 2019
300 ## - PHYSICAL DESCRIPTION
Extent 853-854 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Editorial; Comment
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antibodies, Antinuclear
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Immunoglobulin G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aringer, Martin
773 0# - HOST ITEM ENTRY
Title Arthritis care & research
Related parts vol. 71
-- no. 7
-- p. 853-854
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1002/acr.23714">https://doi.org/10.1002/acr.23714</a>
Public note Available from publisher's website

No items available.